STOCK TITAN

Gossamer Bio (GOSS) Net Income by Year

GOSS

Gossamer Bio reported a net loss of $170.4M in fiscal year 2025. This represents a decrease of 201.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $125.2M net loss. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Gossamer Bio has filed alongside them.

FY2025 annual
Net Income -$170.4M
YoY -201.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

GOSS Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Net Income-$125.2M-$170.4M-201.4%-$56.5M+68.6%-$179.8M+21.6%-$229.4M+2.0%-$234.0M+3.8%-$243.4M-35.0%-$180.3M-22.7%-$147.0M-2070.6%-$6.8M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

GOSS Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income$16.9M+144.2%-$46.7M-27.4%-$47.2M-$48.2M-56.5%-$38.3M-177.7%-$36.6M+12.6%N/A-$30.8M+23.0%$49.2M+215.9%-$41.9M+14.7%N/A-$40.0M+32.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Gossamer Bio financials

Frequently Asked Questions

What was Gossamer Bio's net income in fiscal year 2025?

Gossamer Bio reported a net loss of $170.4M in fiscal year 2025.

How fast is Gossamer Bio's net income growing?

Gossamer Bio (GOSS) net income fell by 201.4% year over year, from -$56.5M to -$170.4M in fiscal year 2025.

What is Gossamer Bio's net income over the last twelve months?

Gossamer Bio (GOSS) reported a $125.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 9 fiscal years this page covers, Gossamer Bio (GOSS) net income went from -$6.8M in fiscal year 2017 to -$170.4M in fiscal year 2025.

Gossamer Bio (GOSS) reported $16.9M in net income in Q2 2026. This represents an increase of 144.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Gossamer Bio (GOSS) reported on that line in every period on record.